Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis
暂无分享,去创建一个
T. Mack | M. Karagas | T. Stukel | A. Swerdlow | E. Holly | V. Bataille | J. Elwood | D. Whiteman | C. Sacerdote | A. Green | B. Armstrong | M. Berwick | R. Zanetti | M. Zens | Yu-Mei Chang | C. Olsen | J. N. Bishop | A. Østerlind | C. Kirkpatrick | A. Green
[1] S. Rosso,et al. Anthropometric factors and risk of melanoma in women: A pooled analysis , 2007, International journal of cancer.
[2] M. Berwick,et al. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.
[3] R. Millikan,et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[4] V. Siskind,et al. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.
[5] J. Stockman,et al. Distinct Sets of Genetic Alterations in Melanoma , 2007 .
[6] L. Naldi,et al. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. , 2006, The Journal of investigative dermatology.
[7] H. Höfler,et al. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study , 2006, Melanoma research.
[8] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[9] R. Gallagher,et al. Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma , 2005, International journal of cancer.
[10] G. Colditz,et al. Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.
[11] G. Severi,et al. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] Shosuke Ito,et al. Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. , 2004, The Journal of investigative dermatology.
[13] T. Mack,et al. Skin characteristics and risk of superficial spreading and nodular melanoma (United States) , 2000, Cancer Causes & Control.
[14] D. Whiteman,et al. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.
[15] Ajay N. Jain,et al. Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.
[16] Daniel Pinkel,et al. Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.
[17] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[18] S. Harrison,et al. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. , 2003, Journal of the American Academy of Dermatology.
[19] S. Rosso,et al. A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use , 2002, British Journal of Cancer.
[20] P. Duray,et al. Neonatal sunburn and melanoma in mice , 2001, Nature.
[21] J. Barrett,et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.
[22] E Demidenko,et al. Two‐stage methods for the analysis of pooled data , 2001, Statistics in medicine.
[23] J. Bulliard,et al. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.
[24] J. Bulliard. Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.
[25] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.
[26] A Biggeri,et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.
[27] M. Delgado-Rodríguez,et al. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body , 1999, The British journal of dermatology.
[28] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[29] M. Berwick,et al. Hormonal and reproductive influences and risk of melanoma in women. , 1998, International journal of epidemiology.
[30] J Cuzick,et al. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.
[31] D. Whiteman,et al. p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.
[32] J. Bulliard,et al. Comparison of the site distribution of melanoma in New Zealand and Canada , 1997, International journal of cancer.
[33] K J Dallimore,et al. Lentigo maligna and lentigo maligna melanoma. , 1997, Journal of the American Academy of Dermatology.
[34] T. Holford,et al. Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.
[35] J. A. Bishop,et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. , 1996, British Journal of Cancer.
[36] D. English,et al. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.
[37] S. Franceschi,et al. Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.
[38] Renato Panizzon,et al. Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.
[39] D. Easton,et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .
[40] E. Holly,et al. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. , 1995, American journal of epidemiology.
[41] J. Elwood,et al. Epidemiological Aspects of Cutaneous Malignant Melanoma , 2012, Developments in Oncology.
[42] E. White,et al. Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. , 1994, American journal of epidemiology.
[43] B. Armstrong. The epidemiology of melanoma: where do we go from here? , 1994 .
[44] M A Weinstock,et al. Epidemiology of melanoma. , 2017, Cancer treatment and research.
[45] N. Martin,et al. Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.
[46] C. Garbe,et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.
[47] J. Elwood,et al. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. , 1990, International journal of epidemiology.
[48] S. Kohn. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. , 1990, The Journal of investigative dermatology.
[49] W. Willett,et al. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.
[50] M. Tucker,et al. The Danish case‐control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women , 1988, International journal of cancer.
[51] M. Tucker,et al. The Danish case‐control study of cutaneous malignant melanoma. I. Importance of host factors , 1988, International journal of cancer.
[52] C. J. O'doherty,et al. Site‐specific melanocytic naevus counts as predictors of whole body naevi , 1988, The British journal of dermatology.
[53] V. Deleo,et al. Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. , 1988, Pigment cell research.
[54] C. J. O'doherty,et al. Benign melanocytic naevi as a risk factor for malignant melanoma. , 1986, British medical journal.
[55] A. Green,et al. Hormonal factors and melanoma in women , 1985, The Medical journal of Australia.
[56] B K Armstrong,et al. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.
[57] V. Beral,et al. Malignant melanoma and oral contraceptive use among women in California. , 1977, British Journal of Cancer.
[58] W. H. Clark,et al. Lentigo maligna and lentigo-maligna melanoma. , 1969, The American journal of pathology.